Treatment of New-Onset Psoriasis Post-Kidney Transplant

Abstract

Psoriasis is a chronic skin disorder with an autoimmune component primarily driven by overactive T cells culminating in an excessive inflammatory response. Patients have reported clearance of their psoriasis after organ transplant, due to their maintenance on immunosuppressive regimens. Flares of psoriasis post-organ transplant are more rare and often require carefully thought-out management plans. Here we report the treatment of a patient who was diagnosed with new-onset psoriasis eight months after a kidney transplant. In discussion with his nephrologist, the decision was made to increase the doses of tacrolimus and mycophenolate mofetil.